These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 25510280)

  • 21. Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
    He Y; Khan S; Huo Z; Lv D; Zhang X; Liu X; Yuan Y; Hromas R; Xu M; Zheng G; Zhou D
    J Hematol Oncol; 2020 Jul; 13(1):103. PubMed ID: 32718354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination-mediated protein degradation and modification: an emerging theme in plant-microbe interactions.
    Zeng LR; Vega-Sánchez ME; Zhu T; Wang GL
    Cell Res; 2006 May; 16(5):413-26. PubMed ID: 16699537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic approaches to identify E3 ligase substrates.
    Iconomou M; Saunders DN
    Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ubiquitin-mediated regulation of TNFR1 signaling.
    Wertz IE; Dixit VM
    Cytokine Growth Factor Rev; 2008; 19(3-4):313-24. PubMed ID: 18515172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timer-based proteomic profiling of the ubiquitin-proteasome system reveals a substrate receptor of the GID ubiquitin ligase.
    Kong KE; Fischer B; Meurer M; Kats I; Li Z; Rühle F; Barry JD; Kirrmaier D; Chevyreva V; San Luis BJ; Costanzo M; Huber W; Andrews BJ; Boone C; Knop M; Khmelinskii A
    Mol Cell; 2021 Jun; 81(11):2460-2476.e11. PubMed ID: 33974913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perilous journey: a tour of the ubiquitin-proteasome system.
    Kleiger G; Mayor T
    Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
    Lub S; Maes K; Menu E; De Bruyne E; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Feb; 7(6):6521-37. PubMed ID: 26695547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
    Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
    Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitination and E3 Ubiquitin Ligases in Rare Neurological Diseases with Comorbid Epilepsy.
    Zhu J; Tsai NP
    Neuroscience; 2020 Jan; 428():90-99. PubMed ID: 31931110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitin-proteasome system in the plant response to abiotic stress: Potential role in crop resilience improvement.
    Xu J; Liu H; Zhou C; Wang J; Wang J; Han Y; Zheng N; Zhang M; Li X
    Plant Sci; 2024 May; 342():112035. PubMed ID: 38367822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.
    Hughes DC; Goodman CA; Baehr LM; Gregorevic P; Bodine SC
    Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1567-C1582. PubMed ID: 37955121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
    Crosas B
    Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
    Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
    Biochem Biophys Res Commun; 2014 Feb; 444(3):290-5. PubMed ID: 24342616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional and unconventional ubiquitination in plant immunity.
    Zhou B; Zeng L
    Mol Plant Pathol; 2017 Dec; 18(9):1313-1330. PubMed ID: 27925369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin-proteasome system and cancer.
    Devoy A; Soane T; Welchman R; Mayer RJ
    Essays Biochem; 2005; 41():187-203. PubMed ID: 16250906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into a functional model of key deubiquitinases UBP12/13 in plants.
    Zhang S; Hu N; Yu F
    New Phytol; 2024 Apr; 242(2):424-430. PubMed ID: 38406992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.